We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+43.29%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.75B
AUM Growth
+$811M
(+42%)
Cap. Flow
+$363M
Cap. Flow
% of AUM
13.21%
Top 10 Holdings %
Top 10 Hldgs %
44.65%
Holding
241
New
88
Increased
39
Reduced
33
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
|
+$36.2M |
| 2 |
Hydrofarm Holdings
HYFM
|
+$19.6M |
| 3 |
Pulmonx
LUNG
|
+$19.2M |
| 4 |
Seer Inc
SEER
|
+$18.7M |
| 5 |
AbCellera Biologics
ABCL
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cooper Companies
COO
|
+$27M |
| 2 |
Inspire Medical Systems
INSP
|
+$11.3M |
| 3 |
PPD
PPD, Inc. Common Stock
PPD
|
+$11.1M |
| 4 |
STAAR Surgical
STAA
|
+$10.4M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$9.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.42% |
| 2 | Industrials | 1.65% |
| 3 | Consumer Staples | 0.32% |
| 4 | Financials | 0.08% |
| 5 | Materials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
PUT
Steris
STE
$23.1B
| $8.81M | 0.32% |
+46,500
| New | +$8.68M |
|
77
Codexis
CDXS
$172M
| $8.4M | 0.31% |
+385,000
| New | +$6.34M |
|
|
NARI
78
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $8.29M | 0.3% |
95,000
+27,500
| +41% | +$1.94M |
|
79
PUT
QuidelOrtho
QDEL
$1.02B
| $8.08M | 0.29% |
45,000
+35,000
| +350% | +$7.78M |
|
80
908 Devices
MASS
$414M
| $7.97M | 0.29% |
+140,000
| New | +$8.18M |
|
|
MTACU
81
DELISTED
MedTech Acquisition Corporation Unit
MTACU
| $7.88M | 0.29% |
+750,000
| New | +$7.82M |
|
|
NVRO
82
PUT
DELISTED
NEVRO CORP.
NVRO
| $7.7M | 0.28% |
+44,500
| New | +$7.21M |
|
83
Turning Point Brands
TPB
$1.73B
| $7.3M | 0.27% |
163,849
+130,611
| +393% | +$4.93M |
|
84
Maravai LifeSciences
MRVI
$861M
| $7.21M | 0.26% |
+257,000
| New | +$7.16M |
|
85
PUT
Sarepta Therapeutics
SRPT
$1.94B
| $6.82M | 0.25% |
+40,000
| New | +$5.93M |
|
86
PUT
Veeva Systems
VEEV
$39.2B
| $6.81M | 0.25% |
25,000
| – | – |
|
87
Quanterix
QTRX
$139M
| $6.57M | 0.24% |
141,175
-10,000
| -7% | -$436K |
|
88
Apyx Medical
APYX
$126M
| $6.5M | 0.24% |
902,847
| – | – |
|
89
Bionano Genomics
BNGO
$13.8M
| $6.47M | 0.24% |
+3,500
| New | +$1.31M |
|
|
BHVN
90
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.43M | 0.23% |
+75,000
| New | +$6.36M |
|
91
Glaukos
GKOS
$11B
| $6.4M | 0.23% |
+85,000
| New | +$5.37M |
|
92
Envista
NVST
$4.61B
| $6.24M | 0.23% |
+185,000
| New | +$5.36M |
|
|
SILK
93
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $6.2M | 0.23% |
98,400
-5,000
| -5% | -$310K |
|
94
PUT
Teleflex
TFX
$6.03B
| $6.17M | 0.22% |
15,000
| – | – |
|
|
MSON
95
DELISTED
Misonix Inc
MSON
| $6.13M | 0.22% |
490,586
| – | – |
|
96
10x Genomics
TXG
$7.52B
| $6.02M | 0.22% |
42,500
-32,220
| -43% | -$4.68M |
|
97
OrthoPediatrics
KIDS
$649M
| $6M | 0.22% |
145,440
-32,978
| -18% | -$1.51M |
|
98
BioLife Solutions
BLFS
$1.71B
| $5.98M | 0.22% |
150,000
-5,000
| -3% | -$170K |
|
99
CALL
ICU Medical
ICUI
$4.48B
| $5.9M | 0.21% |
27,500
+5,000
| +22% | +$970K |
|
|
CMAX
100
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $5.66M | 0.21% |
+12,087
| New | +$4.06M |
|
Similar funds
BCA
RC
DOFI
SCI
LPC
GBCP
SCTC
M
Pura Vida Investments's Q4 2020 Portfolio in Review
As of Q4 2020, Pura Vida Investments held 241 positions worth $2.75B, up 42% from $1.94B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Pura Vida Investments deployed $363M of net new capital in Q4 2020, opening 88 new positions and adding to 39 existing holdings. Its largest new stake was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Inspire Medical Systems, an estimated $11.3M trimmed.
- Pura Vida Investments's largest Q4 2020 buy was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.
- Pura Vida Investments added most to Guardant Health in Q4 2020, an estimated $9.2M increase.
- Pura Vida Investments's biggest Q4 2020 reduction was Inspire Medical Systems, cutting an estimated $11.3M.
- Pura Vida Investments fully exited Cooper Companies in Q4 2020, selling an estimated $27M.
- Pura Vida Investments's ten largest holdings make up 45% of its $2.75B portfolio in Q4 2020.
- Pura Vida Investments opened 88 new positions and closed 64 in Q4 2020.
- Pura Vida Investments's portfolio value rose 42% quarter-over-quarter to $2.75B.
Based on Pura Vida Investments's 13F filing for Q4 2020, filed 16 Feb 2021.